Literature DB >> 15677906

A survey of methodological variation in the Crohn's disease activity index.

Bruce E Sands1, Choon Jin Ooi.   

Abstract

BACKGROUND: The Crohn's disease activity index (CDAI) is the most widely used Crohn's disease activity instrument, yet little is known about the methodological variation in its use.
METHODS: A MEDLINE search was performed to identify authors of articles published from 1976 to 1997 in which the CDAI was used. A multiple-choice questionnaire was sent to all of the authors identified. Questions covered investigators' practice and research characteristics, and details of definitions and techniques applied in scoring the CDAI.
RESULTS: A total of 208 authors were identified, and 100 valid responses were obtained. The respondents were experienced investigators, with 63% of the authors having used the CDAI for > or =7 years. Of these authors, 70% characterized themselves as working in an academic clinical practice, and 72% had participated in industry-sponsored drug studies in which the CDAI was used as an end point. Considerable variation was noted in the administration and scoring of the CDAI, including disagreement on the definition of "liquid or very soft stools," the recording of the number of stools, the recording of pain ratings, and the scoring of extraintestinal manifestations and fistulas. The recording of fever, the scoring for the use of opiates, and the standard for the weight variable also varied widely among respondents.
CONCLUSION: Considerable variation exists in the administration and implementation of the CDAI score among the pool of experienced researchers who were surveyed. This variation may affect the comparability of studies and may introduce random error into the measurement of the CDAI.

Entities:  

Mesh:

Year:  2005        PMID: 15677906     DOI: 10.1097/00054725-200502000-00006

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  10 in total

1.  Inflammatory biomarkers predict relapse in IBD.

Authors:  P Hanaway; A Roseth
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 2.  Current best practice for disease activity assessment in IBD.

Authors:  Alissa J Walsh; Robert V Bryant; Simon P L Travis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-01       Impact factor: 46.802

3.  Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's disease.

Authors:  Chuanpu Hu; Omoniyi J Adedokun; Yang Chen; Philippe O Szapary; Christopher Gasink; Amarnath Sharma; Honghui Zhou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-06-16       Impact factor: 2.745

4.  Emerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature.

Authors:  Gary R Lichtenstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

Review 5.  Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.

Authors:  Carlos Teruel; Elena Garrido; Francisco Mesonero
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 6.  Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease.

Authors:  R W Stidham; T C H Lee; P D R Higgins; A R Deshpande; D A Sussman; A G Singal; B J Elmunzer; S D Saini; S Vijan; A K Waljee
Journal:  Aliment Pharmacol Ther       Date:  2014-04-20       Impact factor: 8.171

Review 7.  Management of active Crohn disease.

Authors:  Adam S Cheifetz
Journal:  JAMA       Date:  2013-05-22       Impact factor: 56.272

8.  Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul.

Authors:  Eun Soo Kim; Minhu Chen; Jun Lee; Chang-Kyun Lee; You Sun Kim
Journal:  Intest Res       Date:  2016-06-27

9.  Disparity in Crohn's disease activity between home and clinics is associated with unscheduled hospital visits due to disease flares.

Authors:  Eun Soo Kim; Yoo Jin Lee; Byung Ik Jang; Kyeong Ok Kim; Eun Young Kim; Hyun Seok Lee; Seong Woo Jeon; Sang Gyu Kwak
Journal:  Korean J Intern Med       Date:  2018-01-17       Impact factor: 2.884

10.  Low FODMAP diet in Egyptian patients with Crohn's disease in remission phase with functional gastrointestinal symptoms.

Authors:  Maha H Elhusseiny; Ali K Amine; Osama E Salem; Dalia I Tayel; Eman A Elsayed
Journal:  JGH Open       Date:  2018-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.